Showing CypComp Card for CC01848: GTS-21 (CypBoM Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:35:15 UTC
Last Updated2019-10-01 21:58:05 UTC
CypComp IDCC01848
Compound Information
NameGTS-21
Structure ImageRpywxzcfypvcnq rvdmupibsa n
InChIKeyRPYWXZCFYPVCNQ-RVDMUPIBSA-N
PubChem ID5310985
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • <22,H;Oxidation;R1>
  • <22,1;Cleavage;R1>
  • <23,H;Oxidation;R2>
  • <23,2;Cleavage;R2>
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <22,H;Oxidation;R1>
  • <22,1;Cleavage;R1>
  • <23,H;Oxidation;R2>
  • <23,2;Cleavage;R2>
  • <22,H;Oxidation;R1>
  • <22,1;Cleavage;R1>
  • <23,H;Oxidation;R2>
  • <23,2;Cleavage;R2>
References
  1. Azuma R, Komuro M, Korsch BH, Andre JC, Onnagawa O, Black SR, Mathews JM: Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease. Xenobiotica. 1999 Jul;29(7):747-62. doi: 10.1080/004982599238362. [PubMed:10456692 ]
Download FileCC01848.sdf